Researchers have developed a spatially-lucid classifier for analyzing immune-tumor relationships and designing new immunotherapies in oncology.The classifier can distinguish between two classes based on the arrangements of their multi-category point sets.Unlike previous techniques, the proposed framework can handle significant spatial variability within a single place-type.Experimental results on real-world MxIF oncology data demonstrate higher prediction accuracy compared to baseline methods.